• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无症状重度主动脉瓣狭窄:诊断与管理中的挑战

Asymptomatic severe aortic stenosis: challenges in diagnosis and management.

作者信息

Izumi Chisato

出版信息

Heart. 2016 Aug 1;102(15):1168-76. doi: 10.1136/heartjnl-2015-309071. Epub 2016 Apr 18.

DOI:10.1136/heartjnl-2015-309071
PMID:27091844
Abstract

Optimal management for asymptomatic severe aortic stenosis (AS) remains controversial. Considering the increase in elderly patients, improved surgical outcomes and the introduction of transcatheter aortic valve implantation, we must reconsider the optimal management of asymptomatic severe AS. In this article, previous studies regarding the natural history of asymptomatic severe AS were reviewed to obtain a clinical perspective of AS in the growing elderly patient population. The incidence of sudden death in asymptomatic severe AS varies among studies from 0.25% to 1.7% per year, with differences related to study design and patient background. Except for very severe AS, sudden death or AS-related cardiac death without preceding symptoms is uncommon if 'watchful' waiting strategy is possible. Therefore, early operation is reasonable in very severe AS, but it is not recommended for all patients with severe AS. Using exercise tests, plasma levels of natriuretic peptides and other parameters, risk stratification of asymptomatic severe AS is needed to select patients who may have greater benefit following early operation. On the other hand, 'watchful' waiting is not always possible in real world of our practice. Patient education and periodic echocardiography are essential in 'watchful' waiting, which is not simply waiting strategy without careful monitoring. Individualised discussion regarding the indication for early operation is necessary, considering age, clinical background, predicted natural history and operative risk in each patient.

摘要

无症状重度主动脉瓣狭窄(AS)的最佳管理仍存在争议。鉴于老年患者数量增加、手术效果改善以及经导管主动脉瓣植入术的引入,我们必须重新考虑无症状重度AS的最佳管理。在本文中,回顾了以往关于无症状重度AS自然病史的研究,以了解在不断增加的老年患者群体中AS的临床情况。无症状重度AS的猝死发生率在不同研究中每年从0.25%到1.7%不等,差异与研究设计和患者背景有关。除了非常严重的AS外,如果可以采用“密切观察”等待策略,无前驱症状的猝死或与AS相关的心脏死亡并不常见。因此,对于非常严重的AS,早期手术是合理的,但不建议对所有重度AS患者都进行早期手术。需要通过运动试验、利钠肽血浆水平和其他参数对无症状重度AS进行风险分层,以选择可能从早期手术中获益更大的患者。另一方面,在我们实际的临床实践中,“密切观察”等待并非总是可行的。患者教育和定期超声心动图检查在“密切观察”等待中至关重要,这并非简单的不进行仔细监测的等待策略。考虑到每个患者的年龄、临床背景、预测的自然病史和手术风险,有必要就早期手术的指征进行个体化讨论。

相似文献

1
Asymptomatic severe aortic stenosis: challenges in diagnosis and management.无症状重度主动脉瓣狭窄:诊断与管理中的挑战
Heart. 2016 Aug 1;102(15):1168-76. doi: 10.1136/heartjnl-2015-309071. Epub 2016 Apr 18.
2
Are transcatheter procedures the treatment of choice for all patients with severe aortic stenosis?经导管手术是所有重度主动脉瓣狭窄患者的首选治疗方法吗?
J Cardiovasc Surg (Torino). 2017 Feb;58(1):132-133. doi: 10.23736/S0021-9509.16.09110-2.
3
Managing heart block after transcatheter aortic valve implantation: from monitoring to device selection and pacemaker indications.经导管主动脉瓣植入术后心脏传导阻滞的管理:从监测到设备选择及起搏器适应证
EuroIntervention. 2015 Sep;11 Suppl W:W101-5. doi: 10.4244/EIJV11SWA30.
4
Dobutamine stress echocardiography for risk stratification of patients with low-gradient severe aortic stenosis undergoing TAVR.多巴酚丁胺负荷超声心动图在经导管主动脉瓣置换术(TAVR)治疗的低跨瓣压差重度主动脉瓣狭窄患者风险分层中的应用
JACC Cardiovasc Imaging. 2015 Mar;8(3):380-382. doi: 10.1016/j.jcmg.2014.09.012. Epub 2014 Nov 12.
5
Watchful waiting care or early intervention in asymptomatic severe aortic stenosis: Where we are.无症状严重主动脉瓣狭窄的静观等待护理或早期干预:我们所处的位置。
Arch Cardiovasc Dis. 2021 Jan;114(1):59-72. doi: 10.1016/j.acvd.2020.07.002. Epub 2020 Nov 3.
6
Prospective Multicenter Evaluation of the Direct Flow Medical Transcatheter Aortic Valve System: 12-Month Outcomes of the Evaluation of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis (DISCOVER) Study.直接血流经导管主动脉瓣系统的前瞻性多中心评估:经皮主动脉瓣 18F 系统治疗严重主动脉瓣狭窄患者的直接血流医学评估 18 个月的结果(DISCOVER)研究。
JACC Cardiovasc Interv. 2016 Jan 11;9(1):68-75. doi: 10.1016/j.jcin.2015.09.027.
7
Asymptomatic Severe Aortic Stenosis in the Elderly.老年人无症状性重度主动脉瓣狭窄。
JACC Cardiovasc Imaging. 2017 Jan;10(1):43-50. doi: 10.1016/j.jcmg.2016.05.015. Epub 2016 Sep 14.
8
Prosthesis-patient mismatch in high-risk patients with severe aortic stenosis: A randomized trial of a self-expanding prosthesis.高危严重主动脉瓣狭窄患者的假体-患者不匹配:自膨式假体的随机试验。
J Thorac Cardiovasc Surg. 2016 Apr;151(4):1014-22, 1023.e1-3. doi: 10.1016/j.jtcvs.2015.10.070. Epub 2015 Oct 28.
9
Transapical transcatheter aortic valve implantation: follow-up to 3 years.经心尖入路经导管主动脉瓣植入术:3 年随访结果。
J Thorac Cardiovasc Surg. 2010 May;139(5):1107-13, 1113.e1. doi: 10.1016/j.jtcvs.2009.10.056.
10
Patient-prosthesis mismatch after transapical aortic valve implantation: incidence and impact on survival.经心尖主动脉瓣植入术后患者-假体不匹配:发生率及对生存率的影响。
J Thorac Cardiovasc Surg. 2013 Feb;145(2):391-7. doi: 10.1016/j.jtcvs.2012.01.043. Epub 2012 Feb 11.

引用本文的文献

1
Comparing Early Intervention to Watchful Waiting: A Review on Risk Stratification and Management in Asymptomatic Aortic Stenosis.比较早期干预与观察等待:无症状主动脉瓣狭窄的风险分层与管理综述
Medicina (Kaunas). 2025 Mar 4;61(3):448. doi: 10.3390/medicina61030448.
2
Wearable devices can predict the outcome of standardized 6-minute walk tests in heart disease.可穿戴设备能够预测心脏病患者标准化6分钟步行测试的结果。
NPJ Digit Med. 2020 Jul 9;3:92. doi: 10.1038/s41746-020-0299-2. eCollection 2020.